Innovative funding partner throughout the growth life-cycle

Latest developments

News, Portfolio 23/11/2022              

Ukio, a premium apartment rental platform for Europe’s ‘flexible workforce,’ raises $28M

Ukio, a short-term furnished apartment rental platform aimed at the “flexible workforce,” has raised €27 million ($28 million) in a Series A round of funding. The cash injection constitutes €17…
News, Portfolio 15/11/2022              

Indivior To Acquire Opiant Pharmaceuticals

RICHMOND, Va., Nov. 14, 2022 /PRNewswire/ -- Indivior PLC (LON: INDV) ("Indivior" or the "Company") and Opiant Pharmaceuticals, Inc. (NASDAQ: OPNT) ("Opiant") today announced that the companies have entered into a definitive agreement…
News, Portfolio 09/11/2022              

Ibex Medical Analytics Secures $10M Funding from Kreos Capital

Kreos Capital, a leading growth debt provider, invests $10 million to accelerate Ibex's AI deployments and new customers, paving way for further expansions TEL AVIV, Israel, Nov. 9, 2022 /PRNewswire/ --  Ibex Medical Analytics (Ibex), the…

Subscribe to our mailing list

Get our newsletter, Kreos updates and information on our events right to your mailbox.

Market Leading Growth Debt Investor for +24 years

Kreos Capital provides innovative and flexible debt solutions to equity-backed, pan-European and Israeli high-growth companies in the technology and healthcare sectors.

For over 24 years, our sole focus has been to support our ambitious ecosystem with personal, adaptable and responsive financing through every stage of the growth life cycle – from entry level through to late-stage growth including pre and post-IPO.